Published November 26, 2022 | Version v1
Journal article Open

Comparison between coronary artery bypass surgery and percutaneous coronary intervention with drug-eluting stents for Egyptian diabetic patients with Multivessel disease

Authors/Creators

  • 1. Critical Care Medicine Department, Cairo University-Egypt

Description

ABSTRACT

Background: With the advances in the interventional field, the usage of DES make the choice of revascularization in diabetic patients with MVD controversial.

Methods: We assigned patients with diabetes and MVD to undergo either PCI with DES or CABG. The patients were followed up for 12 months. The primary outcome was a composite of death, MI, repeated revascularization or stroke.

Results: The study was conducted on 225 patients (116 patients randomly assigned to the PCI group and 109 randomly assigned to the CABG group), 159 males (70.6%), 66 female (29.4%) and their mean age was 57.08±5.79. The mean HbA1c was 7.35%, the mean SYNTAX Score was 24.71, and the mean EuroScore II was 1.04%. No significant differences were seen between CABG and PCI groups in the occurrence of MI at 30 days and 12 months (P = 0.839 and 0.533 respectively), post procedure stroke at 30 days and 12 months (P = 0.234 and 0.612 respectively), for repeated revascularization at 30 days (P = 0.282) and for death at 30 days and 12 months (P = 0.234 and 0.612 respectively). However repeated revascularization after 12 months was significantly higher in PCI with DES group (14 (12.1%) vs 5 (4.6%) patients with P = 0.044).

Conclusions: Diabetic patients with multivessel CAD, comparison between CABG and PCI with DES showed similar mortality, post procedure MI and stroke. However PCI was associated with increased rate of repeat revascularization after 12 months.

Diabetes mellitus, multivessel disease.

Key words: Coronary artery bypass graft, Percutaneous coronary intervention, Diabetes mellitus, Multivessel disease

REFERENCES

  1. Mathew V, Gersh B, Williams B, et al.Outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention in the current era A report from the prevention of restenosis with tranilast and its outcomes (PRESTO) trial. Circulation. 2004; 109(4):476-80.
  2. Suero J, Marso S, Jones P, et al.Procedural outcomes and long-term survival among patients undergoing percutaneous coronary intervention of a chronic total occlusion in native coronary arteries: a 20-year experience. J Am CollCardiol. 2001; 38(2):409-14.
  3. Wijns W, Kolh P, Danchin N, et al.Guidelines on myocardial revascularization The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2010; 31(20):2501-55.
  4. Huang F, Lai W, Chan C et al.Comparison of bypass surgery and drugeluting stenting in diabetic patients with left main and/or multivessel disease: A systematic review and meta-analysis of randomized and nonrandomized studies. Cardiol J. 2015; 22(2):123-34.
  5. Michael T and Schwalm J.Multivessel Disease in the Modern Era of Percutaneous Coronary Intervention, Artery Bypass, Dr Wilbert S. Aronow (Ed.), 2013; ISBN: 978-953-51-1025-5.
  6. Sahn D et al,. Recommendations regarding quantitation in M-mode echocardiography:- results of a survey of echocardiographic measurements. Circulation1978; 58:1072–1083.
  7. Gordon E, et al., Reproducibility of left ventricular volumes by two-dimentional echocardiography. J  Am SocNephrol1983;17:86–89.
  8. Weyman A, Doty W. Left ventricle In Weyman A (ed.) .Ann Intern Med 1982; 139:137–147.
  9. Zoghbi WA, Enriquez-Sarano M, Foster E, et al., Cross-sectional Echocardiography. Lea &Febiger, Philadelphia, 2003; 267-337.
  10. Sianos G, Morel M, Kappetein A, et al.The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention, 2005. 1(2): 219-227.
  11. Nashef S, Roques F, Sharples L, et al., European System for cardiac preoperative risk evaluation (EuroSCORE II). Eur J Cardiothorac Surg. 2012;41:734-745.
  12. Kip K. The problem with composite end points in cardiovascular studies: the story of major adverse cardiac events and percutaneous coronary intervention. J Am CollCardiol. 2008;51(7):701-707.
  13. Sateesh Pujari, & Estari Mamidala. (2015). Anti-diabetic activity of Physagulin-F isolated from Physalis angulata fruits. The American Journal of Science and Medical Research, 1(2), 53–60. https://doi.org/10.5281/zenodo.7352308
  14. Bellomo R, Ronco C, Kellum J A, et al: Acute renal failure: definition, outcome measures, animal models, fluid therapy and information technology needs, The second international consensus conference of the acute dialysis quality initiative (ADQI) group. Critical Care.2004; 4: 204– 212.
  15. Simpfendorfer C, Belardi J, Bellamy G, et al.Frequency, management and follow-up of patients with acute coronary occlusions after percutaneous transluminal coronary angioplasty. Am J Cardiol. 1987;59(4):267–9.
  16. Serruys PW, de Jaegere P, Kiemeneij F, et al.A comparison of balloon expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent study group. N Engl J Med. 1994;331(8):489–495.
  17. Daemen J, Wenaweser P, Tsuchida K, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet. 2007; 369(9562):667–78.
  18. Bangalore S, Toklu B, Amoroso N, et al.Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison metaanalysis. BMJ. 2013; 347:366.
  19. Sarno G, Lagerqvist B, Frobert O, et al.Lower risk of stent thrombosis and restenosis with unrestricted use of ‘new-generation’ drug-eluting stents: a report from the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR). Eur Heart J. 2012; 33(5):606–613.
  20. De Bruyne B, Pijls N, Kalesan B, et al.Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med. 2012;367(11):991– 1001.
  21. Pijls N, Fearon W, Tonino P, et al.Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study. J Am CollCardiol. 2010;56(3):177–184.
  22. Haller J and Olearchyk A.Cardiology’s 10 greatest discoveries. Tex Heart Inst J/Tex Heart Inst St Luke’s Episcopal Hosp Tex Child Hosp. 2002;29(4):342-344.
  23. Hillis L, Smith P, Anderson J, et al.ACCF/ AHA guideline for coronary artery bypass graft surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J ThoracCardiovasc Surg. 2012;143(1):4–34.
  24. Park S, Ahn J, Kim Y, et al.Trial of everolimus-eluting stents or bypass surgery for coronary disease. N Engl J Med. 2015 Mar 26;372(13):1204-1212.
  25. Farkouh M, Domanski M, Sleeper L, et al.Strategies for multivessel revascularization in patients with diabetes. N Engl J Med 2012;367:2375.
  26. Chang T, Leong T, Boothroyd D, et al.Acute kidney injury after CABG versus PCI: an observational study using 2 cohorts. J Am CollCardiol. 2014 Sep 9;64(10):985-994.
  27. Garzillo C, Hueb W, Gersh B, et al.Long-term analysis of left ventricular ejection fraction in patients with stable multivessel coronary disease undergoing medicine, angioplasty or surgery: 10-year follow-up of the MASS II trial. Eur Heart J. 2013 Nov;34(43):3370-3377.
  28. Rubenson D, Tucker C, London E, et al. Two-dimensional echocardiographic analysis of segmental left ventricular wall motion before and after coronary artery bypass surgery. Circulation. 1982 Nov;66(5):1025-1033.

Files

53.1n.pdf

Files (1.1 MB)

Name Size
md5:7c89a3bf884f5aa7475998f485a4642a
1.1 MB Preview Download